| Filed | Description | |
|---|---|---|
| 9/26/25 | 1.02 Agreement Terminated | → |
| 7/24/25 | 1.01 Material Agreement | → |
| 7/22/25 | 1.01 Material Agreement | → |
| 11/13/23 | 1.01 Material Agreement | → |
| 9/6/23 | 1.02 Agreement Terminated | → |
| 12/15/21 | 1.01 Material Agreement | → |
| ↓ 4 more | ||
Unity Biotechnology, Inc. was a publicly traded American biotechnology company that develops drugs that target senescent cells.